Quadriga Biosciences Patents – Insights & Stats (Updated 2023)

Quadriga Biosciences has a total of 65 patents globally, out of which 32 have been granted. Of these 65 patents, more than 63% patents are active. The United States of America is where Quadriga Biosciences has filed the maximum number of patents, followed by Japan and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Quadriga Biosciences.

Quadriga Biosciences was founded in 2015. Quadriga Biosciences is a pharmaceutical corporation. The company discovers and develops exclusive targeted cancer medicines, chemicals, and medications to treat cancer patients. Customers are served by Quadriga Biosciences throughout the state of California.

Do read about some of the most popular patents of Quadriga Biosciences which have been covered by us in this article and also you can find Quadriga Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Quadriga Biosciences patent portfolio.

How many patents does Quadriga Biosciences have?

Quadriga Biosciences has a total of 65 patents globally. These patents belong to 5 unique patent families. Out of 65 patents, 41 patents are active.

How Many Patents did Quadriga Biosciences File Every Year?

Quadriga Biosciences Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantQuadriga Biosciences Applications FiledQuadriga Biosciences Patents Granted
202261
202115
20203
201927
201837
201766
2016193
201528

How many Quadriga Biosciences patents are Alive/Dead?

Worldwide Patents

Quadriga Biosciences Patent Portfolio

How Many Patents did Quadriga Biosciences File in Different Countries?

Quadriga Biosciences Worldwide Patent Filing

Countries in which Quadriga Biosciences Filed Patents

CountryPatent
United States of America13
Japan7
Taiwan4
Australia4
China4
Korea (South)3
Canada3
Europe3
India2
Brazil2
Singapore2
Israel2
Europe1
Europe1
Argentina1
Europe1
New Zealand1
Europe1
Hong Kong (S.A.R.)1
Europe1
South Africa1
Mexico1
Europe1

Where are Research Centers of Quadriga Biosciences Patents Located?

The Research Center for Quadriga Biosciences is the United States of America.

What Percentage of Quadriga Biosciences US Patent Applications Were Granted?

Quadriga Biosciences (Excluding its subsidiaries) has filed 13 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 10 have been granted leading to a grant rate of 76.92%.

Below are the key stats of Quadriga Biosciences patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Quadriga Biosciences?

Law FirmTotal ApplicationsSuccess Rate
Sheppard Mullin Richter & Hampton Llp1376.92%

What are Quadriga Biosciences key innovation segments?

What Technologies are Covered by Quadriga Biosciences?

The chart below distributes patents filed by Quadriga Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Quadriga Biosciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Quadriga Biosciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Quadriga Biosciences?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.